NLRP3 and gout: Results suggest that ER is a potent NLRP3 inhibitor, exerting anti-HUA and anti-gout effects by reducing UA production, enhancing UA excretion, and alleviating inflammation, partly through NLRP3 inflammasome inhibition (59).